2022 American Transplant Congress
Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States
*Purpose: Steroid avoidance in kidney transplantation has been proven non-inferior. Data on steroid avoidance in simultaneous pancreas-kidney (SPK) is scant.*Methods: We utilized the Scientific Registry…2022 American Transplant Congress
Seroprevalence of MMR and Varicella (MMRV) in Solid Organ Transplant Candidates and Seroresponse to MMRV Vaccinations
*Purpose: Updating live vaccines such as MMR and varicella (MMRV) is an important step in preparing patients during the pre-solid organ transplant (SOT) period. While…2022 American Transplant Congress
Organ Donation at a Centralized Donation Facility Compared to Donation at Referral Hospitals
*Purpose: An emerging model of donor management includes utilization of a Specialized Donor Care Facility (SDCF) - essentially a stand-alone OPO-based procurement facility in which…2022 American Transplant Congress
Impact of the Second Year COVID-19 Pandemic on the U.S. Kidney Transplantation: Interrupted Time Series Analysis
*Purpose: The number of kidney transplant (KT) was decreased since the COVID-19 pandemic; however, the magnitude of the pandemic on the number of U.S. KT…2021 American Transplant Congress
Drivers of Graft Failure in Pediatric Kidney Transplant Change Over Time
*Purpose: Short-term pediatric kidney transplant outcomes have improved over time with advanced surgical techniques and better immunosuppression, but long-term graft outcomes remain suboptimal - concerning…2021 American Transplant Congress
Outcomes of Kidney Transplant Recipients (KTRs) Comparing Brain Dead Donors’ vs Donation After Cardiac Death Stratified by KDPI, Focus on Marginal Kidneys: A UNOS Database Analysis
*Purpose: In deceased donor kidney transplantation (DDKT), donation after cardiac death (DCD) is associated with increased cytokine release and renal tubular injury with consequent increase…2021 American Transplant Congress
Utility of Non-Invasive Rejection Biomarkers to Guide Immunomodulation in Kidney Transplant Patients with Active Covid-19 Infection
*Purpose: Treatment of Coronavirus Disease 2019 (COVID-19) infection in organ transplant recipients has involved reduction of immunosuppression (IS). It is plausible that the cytokine release…2021 American Transplant Congress
Racial and Sexual Disparities in Solid Organ Transplant Outcomes Since Implementation of the Affordable Care Act Insurance Expansion Across Some States
*Purpose: Achieving solid organ transplantation traditionally requires access to health insurance. As such, women and people of color have faced barriers to obtaining solid-organ transplants.…2021 American Transplant Congress
Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?
*Purpose: The COVID19 pandemic has affected kidney transplant recipients (KTR) with a wide spectrum of clinical severity. Up to this point, we have solely seen…2021 American Transplant Congress
Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2
Medicine, Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC
*Purpose: The Centers for Disease Control and Prevention identified solid organ transplant (SOT) recipients as persons at high risk to develop severe illness secondary to…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 155
- Next Page »